Key Events This Week
3 Aug: Q1 FY27 results reveal strong revenue growth but margin pressure concerns
4 Aug: Mojo Grade upgraded to Buy following robust quarterly performance
5 Aug: Valuation metrics improve, signalling renewed investor interest
7 Aug: Stock closes the week lower at Rs.158.40, down 7.04%

GPT Healthcare Ltd Valuation Shifts Signal Renewed Investor Interest
2026-08-05 08:03:51GPT Healthcare Ltd has witnessed a notable upgrade in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a shift in price attractiveness amid evolving market dynamics. This micro-cap hospital sector player’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present a more compelling investment case relative to its historical averages and peer group, signalling renewed investor interest despite recent price volatility.
Read full news articleAre GPT Healthcare Ltd latest results good or bad?
2026-08-04 19:22:31GPT Healthcare Ltd's latest financial results for Q1 FY27 reflect a mixed operational performance. The company reported net sales of ₹126.20 crores, which represents a slight sequential decline of 0.13% from ₹126.37 crores in the previous quarter, but shows a robust year-on-year growth of 17.82% compared to ₹107.11 crores in Q1 FY26. This indicates the company's ability to attract patient volumes and expand its service offerings despite a competitive healthcare landscape. However, net profit for the quarter was ₹12.73 crores, marking a sequential decline of 12.63% from ₹14.57 crores in Q4 FY26, although it reflects a significant year-on-year increase of 65.76% from ₹7.68 crores in Q1 FY26. This decline raises questions about cost management and the sustainability of profitability, particularly as the operating margin improved to 19.16%, up from 18.49% in the previous quarter and a notable increase from 16....
Read full news article











